Education
About Us
Working with TipRanks
Follow Us
Mydecine Innovations Group (TSE:MYCO)
:MYCO
MYCO Stock Chart & Stats
Day’s Range― - ―
52-Week Range<C$0.01 - C$0.02
Previous CloseN/A
Volume181.87K
Average Volume (3M)45.60K
Market Cap
C$617.55K
Enterprise ValueC$7.09M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)2.8
Beta-1.17
Next Earnings
Nov 18, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding61,755,398
10 Day Avg. Volume23,329
30 Day Avg. Volume45,601
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Mydecine Innovations Group News
MYCO FAQ
What was Mydecine Innovations Group’s price range in the past 12 months?
Mydecine Innovations Group lowest stock price was <C$0.01 and its highest was C$0.01 in the past 12 months.
What is Mydecine Innovations Group’s market cap?
Mydecine Innovations Group’s market cap is C$617.55K.
When is Mydecine Innovations Group’s upcoming earnings report date?
Mydecine Innovations Group’s upcoming earnings report date is Nov 18, 2025 which is in 80 days.
How were Mydecine Innovations Group’s earnings last quarter?
Currently, no data Available
Is Mydecine Innovations Group overvalued?
According to Wall Street analysts Mydecine Innovations Group’s price is currently Overvalued.
Does Mydecine Innovations Group pay dividends?
Mydecine Innovations Group does not currently pay dividends.
What is Mydecine Innovations Group’s EPS estimate?
Mydecine Innovations Group’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Mydecine Innovations Group have?
Mydecine Innovations Group has 61,755,398 shares outstanding.
What happened to Mydecine Innovations Group’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Mydecine Innovations Group?
Currently, no hedge funds are holding shares in TSE:MYCO
Company Description
Mydecine Innovations Group
Mydecine Innovations Group Inc is a biopharma and life sciences company. It is committed to the research, development, and acceptance of alternative nature-sourced medicine for mainstream use. Reinforcing Mydecine's commitment to mental health solutions is underpinned by the company's three main focuses: Clinical Trials focusing on Veterans, EMS, and First Responders with a PTSD indication; Research and Development building a robust portfolio of intellectual property around drug discovery and unique delivery mechanisms with relevant use patents and future patent applications and Modern technology utilizing for better clinical trial management and mental health wellbeing.
Technical Analysis
Love Pharma Inc
―
NeutriSci International
―
Global Health Clinics
―
Lumiera Health Inc
―
NAVCO Pharmaceuticals Inc
―
Ownership Overview
―
Insiders
―
Mutual Funds
<0.01% Other Institutional Investors
100.00% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---